hepatocellular carcinoma inhibitors (Baruch S Blumberg Institute/Drexel University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehepatocellular carcinoma inhibitors (Baruch S Blumberg Institute/Drexel University)
Drug Alias Namehepatocellular carcinoma inhibitors (Tekmira)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMale genital tract tumorHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaruch S. Blumberg Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOnCore Biopharma IncBaruch S. Blumberg InstituteDrexel University +[4] 
Active IndicationsN/A
Inactive IndicationsMale genital tract tumorHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A